| Dennis Brooks, PHARMD | |
|
White River Medical Center, 1710 Harrison St., Batesville, AR 72501 | |
| (870) 262-1273 | |
| Not Available |
| Full Name | Dennis Brooks |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | White River Medical Center, Batesville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982267712 | NPI | - | NPPES |
| PD07103 | Other | AR | STATE BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD07103 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Brooks, PHARMD Dennis Brooks, 990 E. College St., Batesville, AR 72501 Ph: (870) 834-9139 | Dennis Brooks, PHARMD White River Medical Center, 1710 Harrison St., Batesville, AR 72501 Ph: (870) 262-1273 |
News Archive
Most kidney transplant candidates are willing to receive a kidney from a donor at increased risk of viral infection, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest that kidney disease patients can make rational tradeoffs between the virtues and risks conferred by donated kidneys.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.
Omaha-based Total Wellness, a leading provider of corporate health and wellness services, encourages employers – both large and small – to follow recommendations made by the Center for Disease Control and Prevention (CDC), which encourages employees to receive flu shots this fall.
A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.
› Verified 4 days ago
Brandi West, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1595 Harrison St, Batesville, AR 72501 Phone: 870-793-4179 Fax: 870-793-7303 | |
Dr. Kelly Moran Buffalo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Harrison St, Batesville, AR 72501 Phone: 870-793-3999 Fax: 870-793-8203 | |
Dr. Justin Duane Piker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1045 S St Louis St, Batesville, AR 72501 Phone: 501-344-2036 | |
Laura Simpson-french, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3150 Harrison St, Batesville, AR 72501 Phone: 870-793-4464 | |
Gina A Hodges, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1045 S Saint Louis St, Batesville, AR 72501 Phone: 870-307-0262 | |
James Christopher Hall, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 Aberdeen Dr, Batesville, AR 72501 Phone: 870-799-9161 | |
Andrew G. Strecker, P.A. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 770 S Saint Louis St, Batesville, AR 72501 Phone: 870-793-6816 Fax: 870-793-6817 |